HLA‐haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties
Stefano Giardino,Dirk‐Jan Eikema,Brian Piepenbroek,Mattia Algeri,Mouhab Ayas,Maura Faraci,Abdelghani Tbakhi,Marco Zecca,Mohammed Essa,Bénédicte Neven,Yves Bertrand,Gaurav Kharya,Tatiana Bykova,Sarah Lawson,Mario Petrini,Alexander Mohseny,Fanny Rialland,Beki James,Anca Colita,Mony Fahd,Simone Cesaro,Ansgar Schulz,Katharina Kleinschmidt,Krzysztof Kałwak,Selim Corbacioglu,Carlo Dufour,Antonio Risitano,Régis Peffault de Latour
DOI: https://doi.org/10.1002/ajh.27293
IF: 13.265
2024-03-19
American Journal of Hematology
Abstract:Haploidentical stem cell transplantation (haplo‐SCT) represents the main alternative for children with inherited bone marrow failure syndrome (I‐BMF) lacking a matched donor. This retrospective study, conducted on behalf of the EBMT SAAWP and PDWP, aims to report the current outcomes of haplo‐SCT in I‐BMFs, comparing the different in vivo and ex vivo T‐cell depletion approaches. One hundred and sixty‐two I‐BMF patients who underwent haplo‐SCT (median age 7.4 years) have been registered. Fanconi Anemia was the most represented diagnosis (70.1%). Based on different T‐cell depletion (TCD) approaches, four categories were identified: (1) TCRαβ+/CD19+‐depletion (43.8%); (2) T‐repleted with post‐transplant Cyclophosphamide (PTCy, 34.0%); (3) In‐vivo T‐depletion with ATG/alemtuzumab (14.8%); (4) CD34+ positive selection (7.4%). The cumulative incidences (CI) of neutrophil and platelet engraftment were 84% and 76% respectively, while that of primary and secondary graft failure was 10% and 8% respectively. The 100‐day CI of acute GvHD grade III‐IV(95% CI) was 13%, while the 24‐month CI of extensive chronic GvHD was 4%. After a median follow‐up of 43.4 months, the 2‐year overall survival(OS) and GvHD/Rejection‐free Survival (GRFS) probabilities are 67% and 53%, respectively. The TCR CD3+αβ+/CD19+ depletion group showed a significantly lower incidence of both acute and chronic GvHD and higher OS (79%; p0.013) and GRFS (71%; p
hematology